2020
DOI: 10.12968/ukve.2020.4.1.8
|View full text |Cite
|
Sign up to set email alerts
|

Regenerative medicine in equine orthopaedics: what and when?

Abstract: The development of regenerative medicine has opened up many new therapeutic avenues in veterinary medicine. The focus of regenerative medicine in the horse lies primarily in the musculoskeletal system, where the consequences of injury make tendons, ligaments and joints particularly desirable targets for such interventions. This article focuses on what has been learned from the use of regenerative medicine in naturally-occurring tendon, ligament and joint disease in the horse.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
1
0
2

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 43 publications
0
1
0
2
Order By: Relevance
“… 13 ACS clinical impressions in equine medicine have been disappointing and now it appears that ACS is mainly used as a “maintenance” injection in mild lameness and performance problems. 14 The APS device was designed to address the inflammation associated with osteoarthritis. The APS device has been adopted in large animal medicine, notably equine, and a more recent addition to the canine veterinarian’s tool-kit.…”
Section: Introductionmentioning
confidence: 99%
“… 13 ACS clinical impressions in equine medicine have been disappointing and now it appears that ACS is mainly used as a “maintenance” injection in mild lameness and performance problems. 14 The APS device was designed to address the inflammation associated with osteoarthritis. The APS device has been adopted in large animal medicine, notably equine, and a more recent addition to the canine veterinarian’s tool-kit.…”
Section: Introductionmentioning
confidence: 99%
“…Na medicina veterinária esta enfermidade tem destaque em equinos, principalmente pelo acometimento do tendão flexor digital superficial (TFDS) (Bosch et al, 2010). Tendões são pouco vascularizados e se reparam lentamente quando comparado com outros tecidos moles, em consequência disso, o tratamento tende a ser demorado, culminando em longo período de reabilitação, baixa taxa de sucesso na terapia e alta incidência de recidivas em casos de tendinite (Smith, 2020). A dificuldade na reparação tendínea associada à limitação do completo restabelecimento da função atlética dos pacientes utilizando tratamentos convencionais estimulam o desenvolvimento de estudos com terapias biológicas em busca de resultados terapêuticos mais favoráveis.…”
Section: Introductionunclassified
“…O uso de agentes biológicos, como o plasma rico em plaquetas (PRP) tem sido cada vez mais utilizado na terapia de lesões musculoesqueléticas, no entanto, ainda faltam estudos para o completo conhecimento de seu mecanismo de ação (Smith, 2020). Ainda não se tem o conhecimento consolidado quanto ao momento ideal para sua administração, no entanto, existem evidências que a terapia na fase inicial da lesão tecidual possa acelerar o reparo tendíneo, assim como, melhorar a qualidade do tendão formado (Aguilar-García et al, 2018).…”
Section: Introductionunclassified